Showing results (91-100 of 745) with videos related to
Sort By:
Pageof 75
Circulation Research|June 7, 2014
Lipoproteins as biomarkers and therapeutic targets in the setting of acute coronary syndromeRobert S Rosenson, H Bryan Brewer, Daniel J RaderEuropean Heart Journal. Cardiovascular Pharmacotherapy|September 22, 2022
RNA-targeted therapeutics in cardiovascular disease: the time is nowKonstantin A Krychtiuk, Daniel J Rader, Christopher B GrangerBiochemical Society Transactions|October 31, 2015
Tribbles-1: a novel regulator of hepatic lipid metabolism in humansRobert C Bauer, Batuhan O Yenilmez, Daniel J RaderEndocrinology|May 22, 2002
Perspective: cardiovascular disease in the postgenomic era--lessons learned and challenges aheadJonathan A Epstein, Daniel J Rader, Michael S ParmacekThe Journal of Biological Chemistry|June 29, 2010
Angiopoietin-like protein 3 inhibits lipoprotein lipase activity through enhancing its cleavage by proprotein convertasesJun Liu, Huq Afroza, Daniel J Rader, et al.Clinical Lipidology|April 17, 2012
Gene therapy for dyslipidemia: a review of gene replacement and gene inhibition strategiesSadik H Kassim, James M Wilson, Daniel J RaderCurrent Opinion in Lipidology|February 12, 2011
Functional validation of new pathways in lipoprotein metabolism identified by human geneticsRobert C Bauer, Ioannis M Stylianou, Daniel J RaderJournal of Clinical Lipidology|February 18, 2014
JCL roundtable: drug treatment of severe forms of familial hypercholesterolemiaW Virgil Brown, Daniel J Rader, Anne C GoldbergCurrent Cardiology Reports|September 20, 2012
Targeting high density lipoproteins in the prevention of cardiovascular disease?Daniel B Larach, Emil M deGoma, Daniel J RaderTrends in Molecular Medicine|September 6, 2015
Mining the social mediomeDavid A Asch, Daniel J Rader, Raina M MerchantPageof 75